Cynthia M Rand1, Howard Brill2, Christina Albertin3, Sharon G Humiston4, Stanley Schaffer3, Laura P Shone5, Aaron K Blumkin3, Peter G Szilagyi6. 1. Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York. Electronic address: Cynthia_Rand@urmc.rochester.edu. 2. Monroe Plan for Medical Care, Rochester, New York. 3. Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York. 4. Department of Pediatrics, Children's Mercy Hospitals and Clinics, Kansas City, Missouri. 5. Department of Research, Division of Primary Care Research, American Academy of Pediatrics, Elk Grove Village, Illinois. 6. Mattel Children's Hospital UCLA, Los Angeles, California.
Abstract
PURPOSE: We evaluated a managed care organization (MCO)-generated text message reminder-recall system designed to improve human papillomavirus (HPV) vaccination coverage. METHODS: We conducted a randomized controlled trial of text reminder-recall for parents of 3,812 publicly insured adolescents aged 11-16 years with no prior HPV vaccinations who were enrolled in a single MCO and were patients at one of 39 primary care practices. We determined the rate of HPV receipt for intervention versus control with the Kaplan-Meier failure function and determined hazard ratios using a clustered stratified Cox model, clustering on primary care provider and stratified on practice. We examined results for all subjects, and for those with a valid phone number, stratified by age group (11-13 years and 14-16 years) and gender. A post hoc analysis included all subjects and controlled for age and gender. RESULTS:HPV dose 1 vaccination rates were not significantly different when all participants were included, but for the subset of parents (54%) able to receive messages, HPV dose 1 rates were 13% for the control group and 16% for the intervention group; hazard ratio, 1.3 (95% confidence interval, 1.0-1.6; p = .04), when controlling for age and gender. There were no significant findings in the analysis stratified by age and gender. CONCLUSIONS:MCO-based text reminders are feasible and have a modest effect on HPV dose 1 vaccination rates for those parents able to receive text messages with valid phone numbers in the MCO database. Future studies should examine a similar intervention for those parents who already accepted the first HPV vaccine dose.
RCT Entities:
PURPOSE: We evaluated a managed care organization (MCO)-generated text message reminder-recall system designed to improve human papillomavirus (HPV) vaccination coverage. METHODS: We conducted a randomized controlled trial of text reminder-recall for parents of 3,812 publicly insured adolescents aged 11-16 years with no prior HPV vaccinations who were enrolled in a single MCO and were patients at one of 39 primary care practices. We determined the rate of HPV receipt for intervention versus control with the Kaplan-Meier failure function and determined hazard ratios using a clustered stratified Cox model, clustering on primary care provider and stratified on practice. We examined results for all subjects, and for those with a valid phone number, stratified by age group (11-13 years and 14-16 years) and gender. A post hoc analysis included all subjects and controlled for age and gender. RESULTS:HPV dose 1 vaccination rates were not significantly different when all participants were included, but for the subset of parents (54%) able to receive messages, HPV dose 1 rates were 13% for the control group and 16% for the intervention group; hazard ratio, 1.3 (95% confidence interval, 1.0-1.6; p = .04), when controlling for age and gender. There were no significant findings in the analysis stratified by age and gender. CONCLUSIONS: MCO-based text reminders are feasible and have a modest effect on HPV dose 1 vaccination rates for those parents able to receive text messages with valid phone numbers in the MCO database. Future studies should examine a similar intervention for those parents who already accepted the first HPV vaccine dose.
Authors: David A Fedele; Christopher C Cushing; Alyssa Fritz; Christina M Amaro; Adrian Ortega Journal: JAMA Pediatr Date: 2017-05-01 Impact factor: 16.193
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641
Authors: Peter G Szilagyi; Christina S Albertin; Alison W Saville; Rebecca Valderrama; Abigail Breck; Laura Helmkamp; Xinkai Zhou; Sitaram Vangala; L Miriam Dickinson; Chi-Hong Tseng; Jonathan D Campbell; Melanie D Whittington; Heather Roth; Cynthia M Rand; Sharon G Humiston; Dina Hoefer; Allison Kempe Journal: J Pediatr Date: 2020-06 Impact factor: 4.406
Authors: Peter Szilagyi; Christina Albertin; Dennis Gurfinkel; Brenda Beaty; Xinkai Zhou; Sitaram Vangala; John Rice; Jonathan D Campbell; Melanie D Whittington; Rebecca Valderrama; Abigail Breck; Heather Roth; Megan Meldrum; Chi-Hong Tseng; Cynthia Rand; Sharon G Humiston; Stanley Schaffer; Allison Kempe Journal: Pediatrics Date: 2020-04-06 Impact factor: 7.124
Authors: Jacqueline M Hirth; Abbey B Berenson; Leslie E Cofie; Lena Matsushita; Yong-Fang Kuo; Richard E Rupp Journal: Hum Vaccin Immunother Date: 2019-04-04 Impact factor: 3.452
Authors: Jennifer C Spencer; Noel T Brewer; Justin G Trogdon; Morris Weinberger; Tamera Coyne-Beasley; Stephanie B Wheeler Journal: Pediatrics Date: 2020-11-16 Impact factor: 7.124